Drug intelligence / Profile preview

evodia radix

Development stage
Unknown
Lead developer
The Fifth Medical Center of the PLA General Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Evodia radix, derived from the root of *Evodia rutaecarpa*, is a traditional Chinese medicinal substance being investigated by the Fifth Medical Center of PLA General Hospital for the treatment of chronic non-atrophic gastritis. The pharmacological activity is primarily attributed to quinolone alkaloids such as evodiamine and rutaecarpine. These compounds exhibit potent anti-inflammatory effects by inhibiting the NF-κB signaling pathway and reducing the production of pro-inflammatory cytokines like TNF-α and IL-6. Additionally, evodiamine acts as a transient receptor potential vanilloid 1 (TRPV1) agonist, which may play a role in modulating gastric mucosal blood flow and pain perception. In the context of chronic gastritis, Evodia radix is studied for its ability to protect the gastric mucosa, inhibit *Helicobacter pylori* growth, and alleviate symptoms associated with gastric inflammation.

Other names
Wu Zhu Yu GenRoot of Medicinal EvodiaEvodiae Radix
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on evodia radix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on evodia radix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call